More than 60 organizations, including NVHR, signed onto a letter urging the Trump administration to invest in the Department of Health & Human Services Viral Hepatitis Action Plan and to commit in words and action to the elimination of HBV and HCV in the United States by 2030. You may download a copy of the letter here.
Last Updated on May 13, 2020 by HepFree NYC
The Advisory Committee on Immunization Practices’ (ACIP) recommend HEPLISAV-B™ for use among individuals age 18 years and older to prevent hepatitis B infection (HBV).
The Hep Free NYC LGBTQ Working Group has created a Hepatitis Resource Card for the Lesbian, Gay, Bisexual, Transgender, and Queer community.
As New York State enters this era of successful HCV treatment, the NYSDOH AIDS Institute has developed criteria for defining those providers qualified to manage and treat patients with HCV infection.
The American College of Physicians' High Value Care Task Force and the Centers for Disease Control and Prevention developed this article to present best practice statements for hepatitis B vaccination, screening, and linkage to care.
VOCAL-NY is launching this petition campaign to make sure that people know that we need to create a drug pricing system that can never been exploited again.
The Hepatitis C Program Manager is responsible for the implementation, management, and administration of an AIDS Institute–funded Hepatitis C treatment program.
Ask your State Senator to sign on to the Senate Appropriations letter requesting additional funding for the Division of Viral Hepatitis at the CDC.
Two-thirds of those infected with HBV don’t even realize it! We must ensure that community members, physicians and policy makers are aware of the devastating effects of untreated HBV, and address this issue nationally and globally.
